2004 AUG 10 - (NewsRx.com & NewsRx.net) -- A randomized trial has found that breast cancer patients with four or more positive lymph nodes who receive high-dose chemotherapy with a stem cell transplant have similar survival rates to those who receive conventional chemotherapy.
Previous nonrandomized studies had indicated that there was substantial benefit for patients who received high-dose therapy, according to the study, which appeared in the July 21, 2004, issue of the Journal of the National Cancer Institute (Conventional adjuvant chemotherapy versus single-cycle, autograft-supported, high-dose, late-intensification chemotherapy in high-risk breast cancer …
No comments:
Post a Comment